Literature DB >> 22430773

Correlation between dysplasia and ploidy status in oral leukoplakia.

Andre W van Zyl1, Marlene B van Heerden, Emil Langenegger, Willie F P van Heerden.   

Abstract

Oral leukoplakia and other potentially malignant disorders (PMD) may progress to oral squamous cell carcinoma (OSCC). The gold standard for assessing the potential for malignant transformation remains histologic examination with the aim of grading the dysplastic changes. However, not all lesions with dysplasia will progress to OSCC. DNA ploidy has been suggested as a method to predict the clinical behaviour of PMD. This study reports on the use of high-resolution flow cytometry to determine the ploidy status of formalin-fixed, paraffin-embedded material from PMD compared to their dysplasia grade on histology. Aneuploidy was found in 13 % of mild, 31 % of moderate, and 54 % of severe dysplasia cases. This difference was statistically significant (p = 0.011). The differences in ploidy status were more significant when grouping the dysplasia into low-risk and high-risk categories (p = 0.008). These findings indicate that the ploidy status of PMD as determined by high-resolution flow cytometry may be of value in predicting biological behaviour in PMD such as leukoplakia.

Entities:  

Mesh:

Year:  2012        PMID: 22430773      PMCID: PMC3422580          DOI: 10.1007/s12105-012-0352-9

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  22 in total

1.  Update on oral epithelial dysplasia and progression to cancer.

Authors:  Paul M Speight
Journal:  Head Neck Pathol       Date:  2007-11-30

2.  The value of DNA flow cytometry in predicting the development of lymph node metastasis and survival in patients with locally recurrent oral squamous cell carcinoma.

Authors:  J Hemmer; T Thein; W F Van Heerden
Journal:  Cancer       Date:  1997-06-15       Impact factor: 6.860

3.  Anatomic site based ploidy analysis of oral premalignant lesions.

Authors:  M N Islam; L Kornberg; E Veenker; D M Cohen; I Bhattacharyya
Journal:  Head Neck Pathol       Date:  2009-11-24

4.  Flow cytometric DNA ploidy and recurrence development in squamous cell carcinoma of the oral cavity.

Authors:  J Hemmer; W Vanheerden; E Raubenheimer; J Kreidler; E Schon
Journal:  Int J Oncol       Date:  1996-01       Impact factor: 5.650

5.  Long-term treatment outcome of oral premalignant lesions.

Authors:  P Holmstrup; P Vedtofte; J Reibel; K Stoltze
Journal:  Oral Oncol       Date:  2005-11-28       Impact factor: 5.337

Review 6.  Natural history of potentially malignant oral lesions and conditions: an overview of the literature.

Authors:  Séamus S Napier; Paul M Speight
Journal:  J Oral Pathol Med       Date:  2008-01       Impact factor: 4.253

7.  Abnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinoma.

Authors:  G Bradley; E W Odell; S Raphael; J Ho; L W Le; S Benchimol; S Kamel-Reid
Journal:  Br J Cancer       Date:  2010-09-21       Impact factor: 7.640

8.  DNA aneuploidy and dysplasia in oral potentially malignant disorders: association with cigarette smoking and site.

Authors:  Monica Pentenero; Walter Giaretti; Roberto Navone; Anna Demurtas; Isabella Rostan; Giorgio Bertolusso; Roberto Broccoletti; Paolo Giacomo Arduino; Davide Malacarne; Sergio Gandolfo
Journal:  Oral Oncol       Date:  2009-05-19       Impact factor: 5.337

9.  Flow cytometric DNA ploidy analysis of squamous cell carcinoma of the oral cavity. Comparison with clinical staging and histologic grading.

Authors:  J Hemmer; J Kreidler
Journal:  Cancer       Date:  1990-07-15       Impact factor: 6.860

10.  Oral cancer genesis and progression: DNA near-diploid aneuploidization and endoreduplication by high resolution flow cytometry.

Authors:  Alessandra Donadini; Massimo Maffei; Antonio Cavallero; Monica Pentenero; Davide Malacarne; Emanuela Di Nallo; Mauro Truini; Roberto Navone; Paola Mereu; Marco Scala; Alida Santelli; Sergio Gandolfo; Walter Giaretti
Journal:  Cell Oncol       Date:  2010       Impact factor: 6.730

View more
  7 in total

1.  Correlation Between Histological Grading and Ploidy Status in Oral Leukoplakia, Oral Submucous Fibrosis, and Oral Squamous Cell Carcinoma: A Flow Cytometric Analysis.

Authors:  Surekha Velidandla; Sangameshwar Manikya; Nirosha Gajjada; Sridhar Reddy; Lavanya Gogulamudi; Shivaratna Mediconda
Journal:  J Pharm Bioallied Sci       Date:  2020-08-28

2.  Nucleus Accumbens-Associated Protein 1 Expression Has Potential as a Marker for Distinguishing Oral Epithelial Dysplasia and Squamous Cell Carcinoma.

Authors:  Joji Sekine; Eiji Nakatani; Koichiro Ohira; Katsumi Hideshima; Takahiro Kanno; Yoshiki Nariai; Tatsuo Kagimura; Takeshi Urano
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

3.  Origin of Cancer: An Information, Energy, and Matter Disease.

Authors:  Rainer G Hanselmann; Cornelius Welter
Journal:  Front Cell Dev Biol       Date:  2016-11-17

4.  Prognostic Implications of DNA Repair, Ploidy and Telomerase in the Malignant Transformation Risk Assessment of Leukoplakia.

Authors:  Gigi Thomas; Santhoshkumar Tr; Preethi George S; Thara Somanathan; Santhi Sarojam; Nandakumar Krishnankutti; Hariharan Sreedharan; Ravindran Ankathil
Journal:  Asian Pac J Cancer Prev       Date:  2020-02-01

5.  Oral squamous cell carcinoma in relation to field precancerisation: pathobiology.

Authors:  Liviu L Feller; Razia Rag Khammissa; Beverly B Kramer; Johan J Lemmer
Journal:  Cancer Cell Int       Date:  2013-04-03       Impact factor: 5.722

6.  Predicting malignant progression in clinically high-risk lesions by DNA ploidy analysis and dysplasia grading.

Authors:  Zuraiza Mohamad Zaini; Helen McParland; Henrik Møller; Kate Husband; Edward W Odell
Journal:  Sci Rep       Date:  2018-10-26       Impact factor: 4.379

7.  Diagnostic Utility of Cytology in Assessment of Ploidy Status in Potentially Malignant Oral Disorders.

Authors:  Thayalan Dineshkumar; Prabakar Srikanth; A E Nagarathinam; Krishnan Rajkumar; Shankaran Priyadharini; T A Shruthi
Journal:  Asian Pac J Cancer Prev       Date:  2019-10-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.